As a global network of medical research charities, the Juvenile Diabetes Research Foundation (JDRF) is driving research into new treatments that present tremendous opportunities to deliver enhanced health and wellbeing for people with type-1 diabetes. The technology I am currently most enthused about is glucose responsive insulin, which I think is going to transform how people treat and live with type 1 in the future.
I am very excited by the closed-loop artificial pancreas trial which is now in its final stages. Professor Roman Hovorka at the University of Cambridge is currently perfecting an algorithm that enables a continuous glucose monitor and an insulin pump to talk to each other, and take over the delivery of insulin throughout the day and night, to keep glucose levels in range.

I just wanted to drop you a line and thank you for that post… My lab results at the beginning of the month were 230. After just this last week it’s down to 155. I think I’ll be in normal range within a month. Really miraculous… It’s really been a game changer for me already and I wanted you to know how much I appreciated the info and how much of a difference I think it will make in my life.

The planned Friday announcement by the National Marine Fisheries Service, a division of the Commerce Department, that it will issue the permits to five companies is likely to further antagonize a dozen governors in states on the Eastern Seaboard who strongly oppose the administration’s proposal to expand federal oil and gas leases to the Atlantic. […]

This medical-grade polyester is currently used in teeth guards that kids and adults wear at night, in tiny tubes used to guide the growth of damaged nerve fibers and in surgical sutures.  Researchers are also looking at PCL’s potential as an implant to deliver medications directly to the eyes and to tumors and as a scaffold for growing human tissue.  PCL may be an ideal package for islet cells, the studies note, because it can be used to create thin, flexible membranes with pores that let in glucose and nutrients, let out insulin and exclude bigger immune-system molecules.


Maddy Arnstein has lived with T1D for over 50 years. She became involved with JDRF when she saw the dramatic difference technologies like the insulin pump could have on her life. Maddy was quickly drawn to advocacy—initially to help secure continued renewal of funding for the Special Diabetes Program (SDP). But once she started using a continuous glucose monitor, she dedicated herself to fighting for Medicare coverage.
Anecdotally, Cummings knows at least one person in the US who got their surgery paid for through their partner’s employer insurance, despite only having a BMI of 31. And he notes that many countries with a robust public health care system have already lowered their BMI limits to mirror the DSS-II guidelines, such as the UK and Saudi Arabia. He also believes that Medicare and Medicaid officials are deliberating whether to adopt the DSS-II guidelines, based on discussions he’s had. “I don’t know how long it’ll take, but we’re crossing our fingers and hoping,” he said.
In the picture to the right you can see the lunch that I was unbelievably served at the 11th International Congress on Obesity in Stockholm 2010. This is a major international conference for obesity doctors and scientists. The food contains almost exclusively energy from sugar and starches, things that are broken down to simple sugars in the stomach.
He asked and then demanded that the 200 or so chairs in the middle of the auditorium be rearranged. This required summoning the fire marshal (as the aisle was a matter of code) who insisted that no changes could be made. Brand held his ground. Event planners gathered around him trying to talk him down. Even if it weren’t for the fire code, moving the chairs at this point would have to be done by union workers and would take time. The audience was waiting outside baking in the sun, Hoess, Wanderlust’s CEO, reminded Brand. But he was insistent. I sensed he was willing to threaten to not go on at all when the organizers finally broke down and agreed to move the chairs.

One of the most common ways people with type 2 diabetes attempt to lower their blood sugar is by drastically reducing their intake of carbs. The ADA agrees that carbohydrate counting is essential if you have diabetes, but extreme diets like the ketogenic diet, which reduces carb intake to as little as 5 percent of your daily calories, can be risky for some people with diabetes. (36)
People with diabetes may also worry about trying new foods; traveling; diabetes complications; the toll the condition takes on their family; and healthcare costs, which are 2.3 times higher than for someone without diabetes. For Sandi, she worries about the cost of medication and, if her kidneys worsen, the possibility that she’ll have to go on dialysis. “That’s a really scary thought,” she says.

Creatinine is a chemical waste molecule that is generated from muscle metabolism. Creatinine is produced from creatine, a molecule of major importance for energy production in muscles. Creatinine has been found to be a fairly reliable indicator of kidney function. As the kidneys become impaired the creatinine level in the blood will rise. Normal levels of creatinine in the blood vary from gender and age of the individual.
To determine your best treatment course, the Diabetes Relief team requires a metabolic test during your consultation. This simple, pain-free, highly accurate breathing test takes only about 10 minutes. From there, the medical team can first determine if the treatment will help. Then they will design an individualized blend of traditional diabetic care coupled with a revolutionary infusion therapy and a supplement protocol as the patient’s care plan to “help you get your life back.” All patient care is overseen by Medical Director Lindsey Jackson, MD, PhD, a multidisciplinary physician with expertise in cell biology, wound healing, and hyperbarics, who has significant scientific publications in books and journals.
What medication is available for diabetes? Diabetes causes blood sugar levels to rise. The body may stop producing insulin, the hormone that regulates blood sugar, and this results in type 1 diabetes. In people with type 2 diabetes, insulin is not working effectively. Learn about the range of treatments for each type and recent medical developments here. Read now
×